Veterinary Medicines

HEMOSILATE 125 mg/ml solution for injection

Authorised
  • Etamsylate
Download as PDF

Product identification

Medicine name:
HEMOSILATE 125 mg/ml Ενέσιμο Διάλυμα
HEMOSILATE 125 mg/ml solution for injection
Active substance:
  • Etamsylate
Target species:
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Horse
  • Dog
  • Cat
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Etamsylate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Pig
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
  • Intramuscular use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Goat
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
    • Pig
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB02BX01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Available in:
  • Cyprus
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ecuphar Veterinaria S.L.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • CY00680V
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0281/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 13/06/2025
Download

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download

Package Leaflet

English (PDF)
Published on: 22/12/2023
Download

eu-PUAR-esv0281001-dcp-hemosilate-125-mg-ml-solution-for-injection-en.pdf

English (PDF)
Published on: 22/12/2023
Download